Stock SILVAPHL SILVA PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Silva Pharmaceuticals Limited

Equities

SILVAPHL

BD0493SPL001

Pharmaceuticals

End-of-day quote Dhaka S.E.
Other stock markets
 23:00:00 05/06/2024 BST 		5-day change 1st Jan Change
16.9 BDT -0.59% Intraday chart for Silva Pharmaceuticals Limited -0.59% -21.76%
04-29 Silva Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
01-29 Silva Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

Business Summary

Silva Pharmaceuticals Ltd. is a Bangladesh-based pharmaceuticals company. The Company is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Anti pyretic, Anti-inflammatory Drugs, Anti ulcerants, Antiemetic, Gastroprokinetic, Anti histamine, Anti spasmodic expectorants, Vitamins and Minerals medicines which is selling mainly in local market. The Company produces approximately 187 generic medicines. Its products include tablet, capsule, liquid, and dry syrup. The Company’s products include Actisal, Alvolex, Atechlor, Ambosil, Cipronil, Esosil, Duet, Esypan, Feosi-Z, Glicasil, Multitonic, Multi Gold, Lirel, Omesil, Metlife, Probac, RT-150, Xinoplex, Valpress, Vistasil M, Vasopin Plus, Zoxanid, and others.

Number of employees: 765

Sales per Business

BDT in Million2022Weight2023Weight Delta
Tablet
45.1 %
432 55.4 % 323 45.1 % -25.09%
Capsule
20.5 %
220 28.2 % 147 20.5 % -33.06%
Dry Syrup
19.4 %
61 7.9 % 139 19.4 % +126.56%
Liquid
15.0 %
66 8.5 % 107 15.0 % +62.85%

Sales per region

BDT in Million2022Weight2023Weight Delta
Bangladesh
100.0 %
779 100.0 % 717 100.0 % -7.94%

Managers

Managers TitleAgeSince
Saira Khan CEO
 Chief Executive Officer 43 11/03/17
Mohammad Abul Kasem DFI
 Director of Finance/CFO - -
Khurshid Ahmed Siddique CMP
 Compliance Officer 47 31/01/13
Sujan Kumar Saha IRC
 Investor Relations Contact - -
Salim Ullah Chowdhury SAM
 Sales & Marketing - -
Mohammad Nazmul Haque HRO
 Human Resources Officer - -
Mohammad Iqbal Hossain SEC
 Corporate Secretary 58 23/04/01

Members of the board

Members of the board TitleAgeSince
Silvana Mirza CHM
 Chairman 46 23/04/01
Samina Mirza BRD
 Director/Board Member 40 23/04/01
Farhana Mirza BRD
 Director/Board Member 39 23/04/01
Saira Khan CEO
 Chief Executive Officer 43 11/03/17
Md. Monsur Rahman BRD
 Director/Board Member 39 11/03/17
Mohammad Musfiqur Rahman BRD
 Director/Board Member 59 24/05/17
Mahmuda Akhter BRD
 Director/Board Member - -
Muhammad Moniruzzaman BRD
 Director/Board Member - -

Company contact information

Silva Pharmaceuticals Ltd.

House No. 65 Road No. 8/A New

1209, Dhaka

+

http://www.silvapharma.com
address Silva Pharmaceuticals Limited(SILVAPHL)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
SILVA PHARMACEUTICALS LIMITED Stock Silva Pharmaceuticals Limited
-21.76% 19.65M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+45.82% 765B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.95% 632B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.16% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.86% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.32% 299B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 248B
NOVARTIS AG Stock Novartis AG
+11.88% 216B
ROCHE HOLDING AG Stock Roche Holding AG
-0.78% 219B
AMGEN INC. Stock Amgen Inc.
+5.90% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SILVAPHL Stock
  4. Company Silva Pharmaceuticals Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW